Haleon (HLN) Stock Analysis & Forecast

Nov 16 close

$9.20+0.03 (+0.3%)

Gekko Brief

AI summaryNov 16 close

Haleon's third-quarter organic revenue growth came in below expectations this week, with weak cold and flu consumption and a China supply disruption cited as drags, tightening the near-term growth outlook. Shares fell 2.39% on 9 November, closing at £3.31 and underperforming a rising FTSE 100 Index, and the stock now sits well below its 52-week high of £4.34 reached on 15 October. Separately, Haleon disclosed purchases of 11,006,678 ordinary shares under its buyback program, held as treasury shares, with transactions occurring between 9 and 13 November.

HLN closed at $9.20, up 0.3%, but remains below both its 50-day average of $9.33 and 200-day average of $9.70, with the 50-day also below the 200-day. The stock is down 9.2% over one month, 5.3% over three months, and 7.1% over one year, though up 0.3% over six months. The GekkoIndex reads 59.5, placing it in the Neutral zone, down from a prior reading of -3.1 over five days. Fair value sits at $12.58, putting the current price 26.9% below that mark.

The next earnings date is 4 March 2027, 107 days out and beyond a typical 20-trading-day hold. No insider, Congress, or unusual options activity appears in their respective windows. Seasonality from this point in the calendar has averaged a 6.9% gain over the next 20 trading days across 4 years, rising in 4 of them. Consensus analyst target stands at $10.40, implying 13% upside.

Written by AI from the Nov 16, 2026 close and checked automatically against the figures on this page.

Haleon price vs fair value

$12.26$9.20Nov ’25May ’26Nov ’26
Close $9.20200-day averageGekko Fair Value $12.26

Haleon quick facts

Market cap
$40.38B
P/E ratio
18.7
Forward P/E
15.4
EPS, TTM
$0.49
Revenue, TTM
$11.15B
Profit margin
14.5%
Dividend yield
2.16%
Beta
0.29
Volume
16.09M avg 22.96M
1-year return
−7.1%
Typical daily move
±3.3%
Typical 20-day move
±4.1%
50-day average
$9.33
200-day average
$9.70
Next earnings
Mar 4 before open
Shares outstanding
4.39B
52-week range
$8.38$11.28

Haleon swing-trade checklist

Haleon scores 3 supportive, 1 mixed and 1 headwind across the 5 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

3 supportive1 mixed1 headwind

  • Trendheadwind

    Below 50 and 200-day

    Close $9.20 is below the 50-day ($9.33) and 200-day ($9.70) averages, and the 50-day is below the 200-day.

    See the chart
  • GekkoIndexmixed

    59.5, Neutral

    Reading 59.5 is in the Neutral zone.

    See the GekkoIndex
  • Fair valuesupportive

    25.0% below

    Price is 25% below Gekko Fair Value (more than 5% below).

    See fair value
  • Smart moneyno data

    No data

    No insider, Congress or unusual options activity in the window.

    See smart money
  • Earnings risksupportive

    Reports in 107 days

    Next report Mar 4, 2027, 107 days away — outside a typical 20-trading-day hold.

    See earnings
  • Seasonalitysupportive

    +3.6% on average

    From this point in the calendar, the next 20 trading days averaged +3.6% over 4 years, rising in 3 of them.

    See seasonality

A description of current data, not a recommendation. How this page works

Haleon stock chart and price history

Haleon closed at $9.20 on Nov 16, 2026, −7.1% over the past year, inside a 52-week range of $8.38 to $11.28.

Close50-day average200-day averageVolume
Haleon share price, past year, with 50-day and 200-day moving averages and volume$9$10$11DecJan 2026FebMarAprMayJunJulAugSepOctNov9.20

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
−9.2%
3 months
−5.3%
6 months
+0.3%
1 year
−7.1%
The full HLN chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open HLN in Gekko

Follow Haleon through every session

Put HLN on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track HLN in GekkoFree for 7 days. No credit card required.

About Haleon

Haleon develops, manufactures, and distributes consumer wellness products, covering everything from early research through to getting finished goods onto shelves around the world. Its offerings span oral care, pain relief, respiratory support, and digestive health, along with vitamins, minerals, and other supplements. Among its recognizable names are Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum.

The business operates on an integrated model, running the full chain from scientific development to production and distribution rather than outsourcing these stages separately. Its goods reach consumers across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region, giving it a broad geographic footprint in the markets it serves.

Haleon traces its origins to 2021, when it was formed under the name DRVW 2022 plc before adopting its current name, Haleon plc, in February 2022. The company is headquartered in Brentford, in the United Kingdom, and its shares trade under the ticker HLN.

Sector
Health technology
Website
haleon.com

Haleon GekkoIndex: the smart money zone

Haleon’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 59.5, in the Neutral zone, down 3.1 points over five sessions.

010059.5Neutral

Down 3.1 points over five sessions, from the Accumulation zone.

Reading for Nov 16, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying34+1.0%+1.6%+2.5%+3.5%
Accumulation2110.0%0.0%+0.5%+1.0%
Neutral (current zone)371+0.1%+0.3%+0.7%+2.2%
Distribution44+0.3%−0.4%−1.0%−5.4%
Selling0Not available

Average HLN share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.

Neutral zone: No clear directional signal. About the five zones →

See every daily GekkoIndex reading plotted over the HLN price, zone by zone.Track HLN in Gekko

Is Haleon stock overvalued? Gekko Fair Value

Haleon trades 25.0% below Gekko Fair Value of $12.26, so the shares are undervalued on Gekko’s estimate.

Gekko’s own estimate of what Haleon shares are worth, recalculated every trading day.

$12.26

Gekko Fair Value, Nov 17, 2026

25.0% Undervalued

At the end of Aug 2026 the price was 29.6% below the estimate.

Gekko Fair ValueShare price, month end
$12$9Aug 2026SepOctNov 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open HLN in Gekko

Haleon insider and Congress trading

No open-market insider purchases were filed for Haleon, and no Congress trades were disclosed, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for HLN in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every HLN insider filing, plotted on the chart in Gekko.Open HLN in Gekko

Congress trades last 90 days

No trades in HLN were disclosed by members of Congress in the last 90 days.

From congressional disclosures, which report amounts as ranges.

Congress disclosures for HLN, plotted on the chart in Gekko.Open HLN in Gekko

Haleon earnings: next date and track record

Haleon reports on Mar 4, 2027, before the open (107 days away), and beat the EPS estimate in 4 of its last 8 reports.

4 of 8reports beat the EPS estimate
±1.7%average move across the report
3 of 8reports followed by a gain

Share-price move across each report

−0.7%Oct ’24−0.2%Feb ’25+0.5%Apr ’25+0.2%Jul ’25+2.4%Oct ’25−2.9%Feb ’26−2.4%Apr ’26−4.0%Jul ’26

Last earnings call, Jul 30, 2026 AI summary

What they said
Haleon reported 3.1% organic sales growth in Q2, improving sequentially from 2.2% in Q1, with volume/mix contribution of 1.4%. Emerging markets grew 6.3% despite headwinds in Middle East markets. North America showed 3.1% growth with 2% volume, driven by shelf resets, innovation launches including Centrum Age Defy and clinical repair products, and double-digit e-commerce growth. A&P spending grew 3.2%, representing approximately 21% of sales.
Guidance
Management reaffirmed full-year organic sales growth guidance of 3%-5%, expecting H2 to be stronger than H1. Planned step-up in A&P investment in H2, including increased spend in China Douyin channel and U.S. market activations.
ReportedEPSSurpriseRevenueSurpriseMove
Jul 30, 2026$0.28
est $0.27
+3.6%$7.52B
est $6.40B
+17.5%−4.0%
Apr 29, 2026$0.00
est $0.12
−100.0%——−2.4%
Feb 25, 2026$0.26
est $0.25
+3.4%$7.51B
est $7.57B
−0.8%−2.9%
Oct 30, 2025$0.14
est $0.24
−42.8%$7.52B
est $2.76B
+171.9%+2.4%
Jul 31, 2025$0.24
est $0.24
−0.6%$7.25B
est $7.48B
−3.0%+0.2%
Apr 30, 2025$0.13
est $0.00
———+0.5%
Feb 27, 2025$0.05
est $25.25
−99.8%$7.14B
est $2.74B
+161.2%−0.2%
Oct 31, 2024$0.14
est $0.11
+27.3%$6.93B
est $11.04B
−37.2%−0.7%

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

Haleon stock forecast and analyst price targets

Analysts’ average 12-month price target for Haleon is $10.40, +13.0% from the last close.

$10.40consensus 12-month target, +13.0% from the last close
+0.7%average 20-day move after past Neutral readings
+3.6%average move over the next 20 trading days in the last 4 years
±3.3%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

Haleon seasonality: the next 20 trading days

Over the next 20 trading days from Nov 17, Haleon averaged +3.6% across the last 4 years, rising in 3 of them.

Next 20 trading days, by year

+10.7%2022−1.6%2023+5.1%2024+1.8%2025

Average move and hit rate

WindowAverageYears higher
Next 5 trading days+2.3%3 of 4
Next 10 trading days+2.5%3 of 4
Next 15 trading days+2.8%2 of 4
Next 20 trading days+3.6%3 of 4
Next 30 trading days+5.7%4 of 4

For scale, HLN’s typical 20-trading-day move in either direction is about 4.1%.

Haleon market cap and key statistics

Haleon’s market cap is $40.38B, with a P/E ratio of 18.7 and revenue of $11.15B over the last twelve months.

Valuation

Market cap
$40.38B
P/E ratio
18.7
Forward P/E
15.4
EPS, TTM
$0.49
Gekko Fair Value
$12.26

Trading

Volume
16.09M
Avg volume, 20 days
22.96M
52-week high
$11.28
52-week low
$8.38
Shares outstanding
4.39B

Financials

Revenue, TTM
$11.15B
Profit margin
14.5%
Return on equity
10.1%
Quarterly earnings growth, YoY
−4.5%

Risk and income

Beta
0.29
Typical daily move
±3.3%
Typical 20-day move
±4.1%
Dividend yield
2.16%

Haleon stock news this week

Coverage of Haleon this week reads negative: 1 positive, 0 neutral and 2 negative headlines.

News sentiment negative

More stocks

In the Buying zone today

Reporting earnings this week

Popular on Gekko

More stocks in Health technology

Haleon stock FAQ

What is Haleon’s market cap?

Haleon’s market cap is $40.38B at the Nov 16, 2026 close of $9.20, with 4.39B shares outstanding. The shares trade on a P/E ratio of 18.7.

What is the Haleon stock forecast?

The consensus analyst 12-month price target for Haleon is $10.40, +13.0% from the last close. Gekko doesn’t publish price predictions of its own.

Is Haleon stock overvalued or undervalued?

On Gekko’s estimate Haleon is undervalued: the Nov 16, 2026 close of $9.20 is 25.0% below Gekko Fair Value of $12.26. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does Haleon report earnings next?

Haleon is expected to report on Mar 4, 2027, before the market opens (107 days away). Analysts expect earnings of $0.28 per share on revenue of $7.58B. Haleon beat the earnings estimate in 4 of its last 8 reports, moving 1.7% on average across the report.

What is Haleon’s 52-week high and low?

Haleon’s 52-week high is $11.28 and its 52-week low is $8.38; it closed at $9.20 on Nov 16, 2026, −7.1% over the past year. Over the last five years the shares peaked at $11.42 on Jun 2, 2025.

Is Haleon stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (fair value, earnings risk and seasonality), 1 as mixed (gekkoindex) and 1 as a headwind (trend). The checklist is a description of current data, not a recommendation.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See Haleon the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,476 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.